Dominant Negative Effectors of Heparin Affin Regulatory Peptide (HARP) Angiogenic and Transforming Activities

This publication has 27 references indexed in Scilit:

• New paradigms for the treatment of cancer: The role of anti-angiogenesis agents
  Published by Elsevier ,2000
• Relationship Between Serum Concentrations of the Growth Factor Pleiotrophin and Pleiotrophin-Positive Tumors
  JNCI Journal of the National Cancer Institute, 1998
• Involvement of Receptor-like Protein Tyrosine Phosphatase ζ/RPTPβ and Its Ligand Pleiotrophin/Heparin-binding Growth-associated Molecule (HB-GAM) in Neuronal Migration
  The Journal of cell biology, 1998
• Expression of midkine and pleiotropin in ovarian tumors
  Published by Wolters Kluwer Health ,1998
• Differential expression and biological activity of the heparin-binding growth-associated molecule (HB-GAM) in lung cancer cell lines
  International Journal of Cancer, 1997
• Biochemical and mitogenic properties of the heparin-binding growth factor HARP
  Progress in Growth Factor Research, 1995
• Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice.
  Proceedings of the National Academy of Sciences, 1993
• Cellular distribution of the new growth factor Pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues
  Brain Structure and Function, 1992
• Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin
  Biochemical and Biophysical Research Communications, 1991
• Cloning and Expression of a Developmentally Regulated Protein That Induces Mitogenic and Neurite Outgrowth Activity
  Science, 1990